抗菌药物治疗儿童化脓性关节炎的药物经济学研究  

Pharmacoeconomic Study of Antibacterial Medication Therapy in Children Suppurative Arthritis

作　　者：丁翔宇[1] 张古英[1] 冯卿[2] 李瑞宏[1] 支丽娟[1] 

机构地区：[1]河北省儿童医院,河北石家庄050031 [2]石家庄医学高等专科学校,河北石家庄050061

出　　处：《中国药业》2014年第21期59-60,共2页China Pharmaceuticals

基　　金：河北省卫生厅医学科学研究课题计划;项目编号:20130393

摘　　要：目的探讨儿童化脓性关节炎的最佳药物治疗方案,以最低成本获最佳的治疗效果。方法采用药物经济学方法分析医院2012年1月至2013年12月诊断为化脓性关节炎的65例儿童,根据给药方案分成A组(头孢硫脒)、B组(头孢替唑钠)、C组(头孢曲松钠)、D组(头孢孟多酯钠)4组,进行成本-效果分析。结果 4种治疗方案有效率无统计学差异(P>0.05),B组所用治疗方案成本最小,成本-效果比值最低。结论头孢替唑钠给药方案是治疗儿童化脓性关节炎的最佳方案。Objective To study the optimal medication treatment scheme for obtaining the best effect with the lowest cost in treating children suppurative arthritis. Methods The pharmacoeconomic method was adopted to analyze 65 cases of children suppurative arthritis in our hospital from January 2012 to December 2013. These children cases were divided into the group A,B,C and D according to the medication scheme and performed the cost- effectiveness analysis. Results The effective rate had no statistical difference among the 4treatment groups（ P〉0. 05）,the treatment scheme in the group B（ ceftezole sodium） had the lowest cost,so did the cost- effectiveness ratio. Conclusion The ceftezole sodium regimen is the best scheme for treating children suppurative arthritis.

关 键 词：儿童 抗菌药物 化脓性关节炎 药物经济学 

分 类 号：F407.7[经济管理—产业经济] R969.3[医药卫生—药理学]